The goal is to develop a community focused on designing and developing next generation immunotherapeutics to promote health and prevent and treat disease. We will create a research-to-practice continuum that facilitates this process by linking basic researchers with clinical disease specialists, industry partners and health-care policy experts.
ImmunoT is committed to cultivating a culture of equity, diversity, inclusion, and accessibility. We acknowledge and deeply respect the individual differences, lived experiences, expertise and knowledge of those within our cluster. We welcome all contributions regardless of age, gender identity or sexual orientation, physical ability, race, religion, ancestry, or culture.